期刊文献+

中医药核心指标集(COS-TCM)Delphi实施要点 被引量:2

Key Points of Delphi Survey in the Core Outcome Set of Traditional Chinese Medicine
下载PDF
导出
摘要 德尔菲调查是核心指标集研究中共识环节的重要群体决策方法。中医药核心指标集研究中德尔菲实施过程规范性很重要,实施过程质控不严会影响中医药核心指标集(Core Outcome Set of Traditional Chinese Medicine,COS-TCM)研究的可靠性。为此,本文将对COS-TCM研制中德尔菲调查研究实施过程中问卷的设计、调查方式、平台、轮次、指标遴选原则、条目变动原则、评分与反馈机制、偏倚及丢失数据的控制、参与者等要点进行总结,以期为其他COS-TCM研究德尔菲法的开展提供方法学指导。 Delphi survey is an important group decision making method for the consensus part of the core outcome set study.The standardization of Delphi implementation process in the study of traditional Chinese medicine core outcome set is important.Not strict quality control of implementation process can affect the reliability of the study of Chinese medicine core outcome set(COS-TCM).To this end,this paper summarized the key points,questionnair design,survey methods,platforms,rounds,indicator selection principles,item change principles,scoring and feedback mechanisims,control of bias and missing data,participants in the implementation process of Delphi survey research in COS-TCM development,with a view to providing methodological guidance for the conduct of Delphi method in other TCM core outcome set studies.
作者 张明妍 牛柏寒 蔡慧姿 李凯 张俊华 Zhang Mingyan;Niu Bohan;Chua Huizi;Li Kai;Zhang Junhua(Evidence-Based Medicine Centre,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China;Institute of Chinese Medicine,Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China)
出处 《世界科学技术-中医药现代化》 CSCD 北大核心 2021年第8期2569-2575,共7页 Modernization of Traditional Chinese Medicine and Materia Medica-World Science and Technology
基金 国家自然科学基金委员会资助项目(81473544):中医药临床试验核心指标集(COS-TCM)构建方法研究,负责人:张俊华 国家自然科学基金委员会资助项目(81904056):中医药临床试验核心指标(COS)测评方法学研究,负责人:张明妍
关键词 核心指标集 中医药 德尔菲法 实施要点 Core outcome set Traditional Chinese medicine Delphi survey Implement outline
  • 相关文献

参考文献8

二级参考文献91

  • 1Sinha I P,GaUagher R,Williamson P R,et al.Development of a core outcome set for clinical trials in childhood asthma:a survey of clinicians,parents,and young people.Trials,2012,13:103. 被引量:1
  • 2Kirwan J R,Hewlett S E,Heiberg T,et al.Incorporating the patient perspective into outcome assessment in rheumatoid arthritis:progress at OMERACT 7.J Rheumatol,2005,32(11): 2250-2256. 被引量:1
  • 3Gandhi G Y,Murad M H,Fujiyoshi A,et al.Patient-important outcomes in registered diabetes trials.JAMA,2008,299(21):2543- 2549. 被引量:1
  • 4Sinha I P,Williamson P R,Smyth R L.Outcomes in clinical trials of inhaled corticosteroids for children with asthma are narrowly focused on short term disease activity.PLoS ONE,2009,4(7):e6276. 被引量:1
  • 5World Health Organization.WHO Handbook for Reporting Results of Cancer Treatment.In WHO Offset publication No 48 Geneva:WHO, 1979. 被引量:1
  • 6Miller A B,Hoogstraten B,Staquet M,et al.Reporting results of cancer treatment,Cancer, 1981,47(1):207-214. 被引量:1
  • 7Tugwell P,Boers M.OMERACT conference on outcome measures in rheumatoid arthritis clinical trials:Introduction.J Rheumatol, 1993,20(3):528-530. 被引量:1
  • 8Tugwell P,Boers M,Brooks P,et aI.OMERACT:an international initiative to improve outcome measurement in rheumatology. Trials,2007,8:38. 被引量:1
  • 9OMERACT.http://www.omeract.org/.2013-03-17. 被引量:1
  • 10The COMET Inifialive.http://www.comet-inifiative.org.2013--03-17. 被引量:1

共引文献187

同被引文献32

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部